LAS VEGAS (AP) -- Nevada will collect $3.3 million as part of a multi-state settlement against the manufacturer of an anti-psychotic drug.
Nevada is among 36 states that are sharing the record $181 million settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson.
Nevada Attorney General Catherine Cortez Masto said Thursday that Nevadans have a right to know the risks presented by atypical anti-psychotic drugs.
An investigation found that Janssen improperly marketed four anti-psychotic drugs for unapproved or off-label uses, including treatment of Alzheimer's disease, dementia, depression, and anxiety.
Janssen did not admit wrongdoing but the company has agreed to change how it promotes and markets the drugs.
Copyright 2017 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.